-
1
-
-
0038204340
-
HIV lipodystrophy: Risk factors, pathogenesis, diagnosis and management
-
Carr A: HIV lipodystrophy: Risk factors, pathogenesis, diagnosis and management. AIDS 2003;17:S141-S148. (Pubitemid 36667790)
-
(2003)
AIDS
, vol.17
, Issue.SUPPL. 1
-
-
Carr, A.1
-
2
-
-
33646884392
-
Les lipodystrophies secondaires aux traitements antirétrovî raux de l'infection par le VIH
-
Capeau J, Caron M, Vigouroux C, et al.: Lipodystrophies related to antiretroviral treatment of HIV infection. Med SCi (Paris) 2006;22 (5):531-536. (Pubitemid 43778687)
-
(2006)
Medecine/Sciences
, vol.22
, Issue.5
, pp. 531-536
-
-
Copeau, J.1
Caron, M.2
Vigoureux, C.3
Cervera, P.4
Kim, M.5
Maachi, M.6
Lagathu, C.7
Bastard, J.-P.8
-
3
-
-
20544462320
-
Pathophysiology of the HIV-associated lipodystrophy syndrome
-
DOI 10.1089/met.2004.2.274
-
Fève B, Glorian M, and El Hadri K: Pathophysiology of the HIV-associated lipodystrophy syndrome. Metabol Syndr Related Disord 2004;2(4):274-286. (Pubitemid 40846900)
-
(2004)
Metabolic Syndrome and Related Disorders
, vol.2
, Issue.4
, pp. 274-286
-
-
Feve, B.1
Glorian, M.2
El Hadri, K.3
-
4
-
-
67651096095
-
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
-
Haubrich RH, Riddler SA, DiRienzo AG, et al.: Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS 2009;23(9):1109-1118.
-
(2009)
AIDS
, vol.23
, Issue.9
, pp. 1109-1118
-
-
Haubrich, R.H.1
Riddler, S.A.2
Dirienzo, A.G.3
-
5
-
-
84857035135
-
Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy
-
De Luca A, Nasi M, Di Giambenedetto S, et al.: Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy. J Acquir Immune Defic Syndr 2012;59(2):113-120.
-
(2012)
J Acquir Immune Defic Syndr
, vol.59
, Issue.2
, pp. 113-120
-
-
De Luca, A.1
Nasi, M.2
Di Giambenedetto, S.3
-
6
-
-
38049072577
-
A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: The ANRS EP29 Lipostop Study
-
Kim MJ, Leclercq P, Lanoy E, et al.: A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: The ANRS EP29 Lipostop Study. Antivir Ther 2007;12(8):1273-1283.
-
(2007)
Antivir Ther
, vol.12
, Issue.8
, pp. 1273-1283
-
-
Kim, M.J.1
Leclercq, P.2
Lanoy, E.3
-
7
-
-
77952420363
-
HIV-associated lipodystrophy: From fat injury to premature aging
-
Caron-Debarle M, Lagathu C, Boccara F, et al.: HIV-associated lipodystrophy: From fat injury to premature aging. Trens Mol Med 2010;16(5):218-229.
-
(2010)
Trens Mol Med
, vol.16
, Issue.5
, pp. 218-229
-
-
Caron-Debarle, M.1
Lagathu, C.2
Boccara, F.3
-
8
-
-
55049134099
-
Lipodystrophy and quality of life of HIV-infected persons
-
Guaraldi G, Muuri R, Orlandoa G, et al.: Lipodystrophy and quality of life of HIV-infected persons. AIDS 2008;10(3): 152-161.
-
(2008)
AIDS
, vol.10
, Issue.3
, pp. 152-161
-
-
Guaraldi, G.1
Muuri, R.2
Orlandoa, G.3
-
9
-
-
54049143875
-
Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy
-
Crane HM, Grunfeld C, Harrington RD, et al.: Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy. HIV Med 2008; (9):780-786.
-
(2008)
HIV Med
, vol.9
, pp. 780-786
-
-
Crane, H.M.1
Grunfeld, C.2
Harrington, R.D.3
-
10
-
-
0037395720
-
A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals
-
DOI 10.1136/sti.79.2.137
-
Power R, Tate HL, McGill SM, and Taylor C: A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sex Transm Infect 2003;79:137-141. (Pubitemid 36469620)
-
(2003)
Sexually Transmitted Infections
, vol.79
, Issue.2
, pp. 137-141
-
-
Power, R.1
Tate, H.L.2
McGill, S.M.3
Taylor, C.4
-
11
-
-
0035086247
-
Lipodystrophy syndrome in patients with HIV infection: Quality of life issues
-
Martinez E, Garcia-Viejo MA, and Blanch L: Lipodystrophy syndrome in patients with HIV infection: Quality of life issues. Drug Saf 2001;24:157-166. (Pubitemid 32250939)
-
(2001)
Drug Safety
, vol.24
, Issue.3
, pp. 157-166
-
-
Martinez, E.1
Garcia-Viejo, M.A.2
Blanch, J.3
Gatell, J.M.4
-
12
-
-
25844473170
-
Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Fat distribution in men with HIV infection
-
Bacchetti P, Gripshover B, Grunfeld C, et al.: Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr 2005;40(2):121-131.
-
(2005)
J Acquir Immune Defic Syndr
, vol.40
, Issue.2
, pp. 121-131
-
-
Bacchetti, P.1
Gripshover, B.2
Grunfeld, C.3
-
13
-
-
20444387610
-
Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women
-
DOI 10.1086/430379
-
Jacobson DL, Knox T, Spiegelman D, et al.: Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women. Clin Infect Dis 2005;40:1837-1845. (Pubitemid 40799956)
-
(2005)
Clinical Infectious Diseases
, vol.40
, Issue.12
, pp. 1837-1845
-
-
Jacobson, D.L.1
Knox, T.2
Spiegelman, D.3
Skinner, S.4
Gorbach, S.5
Wanke, C.6
-
14
-
-
0042131994
-
HIV lipodystrophy: Prevalence, severity and correlates of risk in Australia
-
DOI 10.1046/j.1468-1293.2003.00159.x
-
Miller J, Carr A, Emery S, et al.: HIV lipodystrophy: Prevalence, severity and correlates of risk in Australia. HIV Med 2003;4:293-301. (Pubitemid 36949887)
-
(2003)
HIV Medicine
, vol.4
, Issue.3
, pp. 293-301
-
-
Miller, J.1
Carr, A.2
Emery, S.3
Law, M.4
Mallal, S.5
Baker, D.6
Smith, D.7
Kaldor, J.8
Cooper, D.A.9
-
15
-
-
0037093813
-
Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy
-
DOI 10.1086/339866
-
Saves M, Raffi F, Capeau J, et al. and the Antiproteases Cohorte (APROCO) Study Group: Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis 2002;34:1396-1405. (Pubitemid 34507951)
-
(2002)
Clinical Infectious Diseases
, vol.34
, Issue.10
, pp. 1396-1405
-
-
Saves, M.1
Raffi, F.2
Capeau, J.3
Rozenbaum, W.4
Ragnaud, J.-M.5
Perronne, C.6
Basdevant, A.7
Leport, C.8
Chene, G.9
Salamon, R.10
Brun-Vezinet, F.11
Fleury, H.12
Peytavin, G.13
Moatti, J.-P.14
Pierret, J.15
Costagliola, D.16
Dellamonica, P.17
Katlama, C.18
Meyer, L.19
Morin, M.20
Sicard, D.21
Sobel, A.22
Vincent-Ballereau, F.23
Dupon, M.24
Le Moing, V.25
Marchou, B.26
May, T.27
Morlat, P.28
Waldner-Combernoux, A.29
Bard, J.-M.30
Coussieu, C.31
Gharakhanian, S.32
Krempf, M.33
Alfaro, C.34
Barennes, C.35
Cailleton, V.36
Carrieri, M.P.37
Deveaud, C.38
Droz, C.39
Dupouy, G.40
Duran, S.41
Dutoit, S.42
Ecobichon, J.L.43
Egouy, C.44
Germain, C.45
Jadand, C.46
Journot, V.47
Lassalle, R.48
Latour, L.49
Lawson-Ayayi, S.50
Le Moing, V.51
Lewden, C.52
Masquelier, B.53
Nouioua, W.54
Palmer, G.55
Pereira, E.56
Roloff, S.57
Ronde-Ousteau, V.58
Sangue, A.59
Souville, M.60
Spire, B.61
Surzyn, J.62
Winum, R.63
Chennebault, J.-M.64
Faller, J.-P.65
Estavoyer, J.M.66
Laurent, R.67
Vuitton, D.68
Beylot, J.69
Lacut, J.-Y.70
Le Bras, M.71
Ragnaud, J.-M.72
Granier, P.73
Garre, M.74
Bazin, C.75
Veyssier, P.76
Devidas, A.77
Sobel, A.78
Perronne, C.79
Lagarde, P.80
Ceccaldi, J.81
Peyramond, D.82
Allard, C.83
Reynes, J.84
Canton, P.85
Cassuto, J.-P.86
Arsac, P.87
Bricaire, F.88
Caulin, C.89
Frottier, J.90
Herson, S.91
Imbert, J.-C.92
Malkin, J.-E.93
Vachon, F.94
Vilde, J.-L.95
Becq-Giraudon, B.96
Remy, G.97
Cartier, F.98
Roue, R.99
more..
-
16
-
-
18044376212
-
Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection Aquitaine cohort, France, 1999
-
Thiebaut R, Daucourt V, Mercie P, et al.: Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection Aquitaine cohort, France, 1999. Clin Infect Dis 2000;31:1482-1487.
-
(2000)
Clin Infect Dis
, vol.31
, pp. 1482-1487
-
-
Thiebaut, R.1
Daucourt, V.2
Mercie, P.3
-
17
-
-
25844487693
-
Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children
-
DOI 10.1097/01.qai.0000178930.93033.f2
-
Beregszaszi M, Dollfus C, and Levine M: Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children. J Acquir Immune Defic Syndr 2005;40(2):161-168. (Pubitemid 41395714)
-
(2005)
Journal of Acquired Immune Deficiency Syndromes
, vol.40
, Issue.2
, pp. 161-168
-
-
Beregszaszi, M.1
Dollfus, C.2
Levine, M.3
Faye, A.4
Deghmoun, S.5
Bellal, N.6
Houang, M.7
Chevenne, D.8
Hankard, R.9
Bresson, J.-L.10
Blanche, S.11
Levy-Marchal, C.12
-
18
-
-
84859374751
-
Body fat abnormality in HIV-infected children and adolescents living in Europe: Prevalence and risk factors
-
Alam N, Cortina-Borja M, Goetghebuer T, et al.: Body fat abnormality in HIV-infected children and adolescents living in Europe: Prevalence and risk factors. J Acquir Immune Defic Syndr 2012;59(3):314-324.
-
(2012)
J Acquir Immune Defic Syndr
, vol.59
, Issue.3
, pp. 314-324
-
-
Alam, N.1
Cortina-Borja, M.2
Goetghebuer, T.3
-
19
-
-
84876911087
-
-
Report July 2010: Recommendations of the Expert Group under the direction of Professor Patrick Yeni. Ed. La Documentation Française (Paris)
-
Medical care of persons infected with HIV: Report, July 2010: Recommendations of the Expert Group under the direction of Professor Patrick Yeni. Ed. La Documentation Française (Paris), 2010.
-
(2010)
Medical Care of Persons Infected with HIV
-
-
-
20
-
-
68449103044
-
Clinical management of HIV-associated lipodystrophy
-
Pirmohamed M: Clinical management of HIV-associated lipodystrophy. Curr Opin Lipido 2009;20(4):309-314.
-
(2009)
Curr Opin Lipido
, vol.20
, Issue.4
, pp. 309-314
-
-
Pirmohamed, M.1
-
21
-
-
78650404394
-
Review and evaluation of treatment procedures using injectable poly-L-lactic acid in the treatment of human immunodeficiency virus-associated facial lipoatrophy
-
Mest D and Humble G: Review and evaluation of treatment procedures using injectable poly-L-lactic acid in the treatment of human immunodeficiency virus-associated facial lipoatrophy. J Clin Aesthet Dermatol 2010;3(12):43-49.
-
(2010)
J Clin Aesthet Dermatol
, vol.3
, Issue.12
, pp. 43-49
-
-
Mest, D.1
Humble, G.2
-
22
-
-
77951260843
-
A meta-analysis of six placebo controlled trials of thiazolidenedione therapy for HIV lipoatrophy
-
Raboud JM, Diong C, Carr A, et al.: A meta-analysis of six placebo controlled trials of thiazolidenedione therapy for HIV lipoatrophy. HIV Clin Trials 2010;11(1):39-50.
-
(2010)
HIV Clin Trials
, vol.11
, Issue.1
, pp. 39-50
-
-
Raboud, J.M.1
Diong, C.2
Carr, A.3
-
23
-
-
0036860765
-
HIV-associated facial lipoatrophy
-
DOI 10.1046/j.1524-4725.2002.02099.x
-
James J, Carruthers A, and Carruthers J: HIV-associated facial lipoatrophy. Dermatol Surg 2002;28(11):979-986. (Pubitemid 35424794)
-
(2002)
Dermatologic Surgery
, vol.28
, Issue.11
, pp. 979-986
-
-
James, J.1
Carruthers, A.2
Carruthers, J.3
-
24
-
-
30744462299
-
Quality of life and body image in the assessment of psychological impact of lipodystrophy: Validation of the Italian version of Assessment of Body Change and Distress questionnaire
-
DOI 10.1007/s11136-005-8342-y
-
Guaraldi G, Orlando G, Murri R, et al.: Quality of life and body image in the assessment of psychological impact of lipodystrophy: Validation of the Italian version of assessment of body change and distress questionnaire. Qual Life Res 2006;15:173-178. (Pubitemid 43097598)
-
(2006)
Quality of Life Research
, vol.15
, Issue.1
, pp. 173-178
-
-
Guaraldi, G.1
Orlando, G.2
Murri, R.3
Vandelli, M.4
De Paola, M.5
Beghetto, B.6
Nardini, G.7
Ciaffi, S.8
Vichi, F.9
Esposito10
Wu, A.W.11
-
25
-
-
0017360990
-
The measurement of observer agreement for categorical data
-
Landis JR and Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174. (Pubitemid 8054849)
-
(1977)
Biometrics
, vol.33
, Issue.1
, pp. 159-174
-
-
Landis, J.R.1
Koch, G.G.2
-
26
-
-
34247866461
-
Association between hepatitis C virus coinfection and regional adipose tissue volume in HIV-infected men and women
-
DOI 10.1097/QAI.0b013e3180423a95
-
Tien PC, Bacchetti P, Gripshover B, Overton ET, Rimland D, and Kotler D: Association between hepatitis C virus coinfection and regional adipose tissue volume in HIV-infected men and women. J Acquir Immune Defic Syndr 2007;45(1):60-65. (Pubitemid 46691099)
-
(2007)
Journal of Acquired Immune Deficiency Syndromes
, vol.45
, Issue.1
, pp. 60-65
-
-
Tien, P.C.1
Bacchetti, P.2
Gripshover, B.3
Overton, E.T.4
Rimland, D.5
Kotler, D.6
-
27
-
-
67649173131
-
Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4-to 9-year antiretroviral therapy in Senegal: A case-control study
-
Mercier S, Gueye NF, Cournil A, et al.: Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4-to 9-year antiretroviral therapy in Senegal: A case-control study. J Acquir Immune Defic Syndr 2009;51(2):224-230.
-
(2009)
J Acquir Immune Defic Syndr
, vol.51
, Issue.2
, pp. 224-230
-
-
Mercier, S.1
Gueye, N.F.2
Cournil, A.3
-
28
-
-
15044346198
-
Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients
-
DOI 10.1097/01.qai.0000152834.02912.98
-
Lafaurie M, Dolivo M, and Porcher R: Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients. J Acquir Immune Defic Syndr 2005; 38:393-398. (Pubitemid 40381548)
-
(2005)
Journal of Acquired Immune Deficiency Syndromes
, vol.38
, Issue.4
, pp. 393-398
-
-
Lafaurie, M.1
Dolivo, M.2
Porcher, R.3
Rudant, J.4
Madelaine, I.5
Molina, J.-M.6
-
29
-
-
56549130063
-
Impact of lipoatrophy on quality of life in HIV patients receiving antiretroviral therapy
-
Rajagopalan R, Laitinen D, and Dietz B: Impact of lipoatrophy on quality of life in HIV patients receiving antiretroviral therapy. AIDS Care 2008;20(10):1197-2201.
-
(2008)
AIDS Care
, vol.20
, Issue.10
, pp. 1197-2201
-
-
Rajagopalan, R.1
Laitinen, D.2
Dietz, B.3
-
30
-
-
84859767597
-
The development of PROQOL-HIV: An international instrument to assess the health-related quality of life of persons living with HIV/AIDS
-
Duracinsky M, Herrmann S, Berzins B, et al.: The development of PROQOL-HIV: An international instrument to assess the health-related quality of life of persons living with HIV/AIDS. J Acquir Immune Defic Syndr 2012;59(5):498-505.
-
(2012)
J Acquir Immune Defic Syndr
, vol.59
, Issue.5
, pp. 498-505
-
-
Duracinsky, M.1
Herrmann, S.2
Berzins, B.3
-
31
-
-
84858124245
-
Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: Results of the LIPOPHILL open-label study
-
Mole B, Gillaizeau F, Carbonnel E, et al.: Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: Results of the LIPOPHILL open-label study. AIDS Res Hum Retroviruses 2012;28(3):251-258.
-
(2012)
AIDS Res Hum Retroviruses
, vol.28
, Issue.3
, pp. 251-258
-
-
Mole, B.1
Gillaizeau, F.2
Carbonnel, E.3
|